MedTrace Logo

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

NCT01270555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2013-03-08

Study results available
· View outcomes & findings →

Summary

The investigators propose to conduct an open study to evaluate the efficacy and tolerability of Bupropion SR using clinically relevant doses in ADHD adults with a recent history of or current substance use disorders. We hypothesize that Bupropion SR will be effective in treating ADHD in this population.

Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Substance Use Disorder (SUD)

Interventions

DRUG

Bupropion SR

100mg capsules Initial dosing 100mgSR every morning, to be titrated to 200mgSR twice daily maximum

Sponsors & Collaborators

  • Massachusetts General Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-05-31
Primary Completion
2001-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01270555 on ClinicalTrials.gov